Martina Musella
Istituto di Patologia Generale
Università Cattolica del Sacro Cuore
Martina Musella has not added Biography.
If you are Martina Musella and would like to personalize this page please email our Author Liaison for assistance.
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
Oncotarget May, 2016 | Pubmed ID: 27028869
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.
Oncoimmunology , 2017 | Pubmed ID: 28638743
Assessment of IFN-γ and granzyme-B production by in "sitro" technology.
Methods in enzymology , 2020 | Pubmed ID: 31948559
Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies.
Methods in enzymology , 2020 | Pubmed ID: 32000907
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.
Frontiers in immunology , 2020 | Pubmed ID: 33193295
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.
Cell death and differentiation Feb, 2021 | Pubmed ID: 33531658
The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition.
Cancers Apr, 2021 | Pubmed ID: 33921638
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation.
Biology Sep, 2021 | Pubmed ID: 34571733
Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?
Biology Sep, 2021 | Pubmed ID: 34571790
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
Cells Sep, 2021 | Pubmed ID: 34572009
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nature immunology Sep, 2022 | Pubmed ID: 36002648
3D cancer models: One step closer to human studies.
Frontiers in immunology , 2023 | Pubmed ID: 37114038
Epigenetics behind tumor immunology: a mini review.
Oncogene Sep, 2023 | Pubmed ID: 37604925
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
Journal of translational medicine Nov, 2023 | Pubmed ID: 37996891
In Vitro Evaluation of Cancer Cell Immunogenicity and Antigen-Specific T-Cell Cytotoxicity by Flow Cytometry.
Methods in molecular biology (Clifton, N.J.) , 2024 | Pubmed ID: 38070104
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유